Apollomics, Inc. (APLM) vs Connect Biopharma Holdings Limited (CNTB)
A side-by-side comparison of Apollomics, Inc. and Connect Biopharma Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.47HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
CNTB
Connect Biopharma Holdings Limited
$0.92HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — APLM vs CNTB
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)CNTB -80.3% (-27.7%/yr)CNTB compounded faster over this window
Log scale — wide-divergence pair
APLM CNTB
APLM vs CNTB: by the numbers
- •CNTB is the larger company ($58M vs $49M market cap).
- •Both run net losses; APLM's is the smaller (-128.69% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | APLM | CNTB |
|---|---|---|
| P/B ratio | N/A | 2.15 |
Profitability
| Metric | APLM | CNTB |
|---|---|---|
| Gross margin | 97.00% | 100.00% |
| Operating margin | -111.45% | -90740.62% |
| Net margin | -128.69% | -86687.50% |
| ROE | N/A | -132.16% |
| ROIC | -2441.49% | -136.77% |
Growth (annualized)
| Metric | APLM | CNTB |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
| Total return CAGR (5Y) | N/A | -47.22% |
Go deeper
Dig into the metrics
Apollomics ROEConnect Biopharma ROEApollomics operating marginConnect Biopharma operating marginApollomics revenue growthConnect Biopharma revenue growthApollomics free cash flowConnect Biopharma free cash flow
Apollomics & Connect Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.